Kahweol (Arabica Coffee Furanoid Diterpene · Anti-angiogenic · Hepatoprotective)

Compound	Kahweol
Chemical class	Terpenoid — Diterpene (Kaurane-type; furan-ring-containing coffee diterpene)
CAS	6894-43-5
Primary source	Coffea arabica (Arabica coffee beans; virtually absent in robusta)
Key applications	Anti-inflammatory; antiproliferative (cancer); hepatoprotective; LDL-raising (same as cafestol); Arabica-specific marker
Claim strength	Moderate
Typical form	Green coffee oil (co-delivered with cafestol); kahweol isolate (research grade)
Buy from Herbuno	Coffee Senna Extract Powder - Senna occidentalis | Sonamukhi → Green Coffee Extract Powder - Coffea arabica →

Name origin: From kahve (Turkish: coffee) + -ol (alcohol). Kahweol is structurally identical to cafestol except for a furanoid ring double bond at C-16,17 — the furan oxygen-containing five-membered ring fused to the diterpene D-ring, absent in cafestol. This single structural difference (an additional double bond forming the furan ring) gives kahweol distinct additional pharmacological properties, particularly its more potent antiproliferative and anti-carcinogenic activity. Kahweol is present only in Coffea arabica — its absence from robusta makes it a chemotaxonomic marker distinguishing arabica from robusta coffee (relevant to coffee adulteration testing). Complementary pharmacology to cafestol: Kahweol and cafestol share LDL-cholesterol-raising activity (same FXR/PXR mechanism) and Nrf2-activating hepatoprotective activity. Where they differ: kahweol has significantly more potent antiproliferative and anti-angiogenic activity in cancer cell models, attributed to the furan ring’s additional electrophilic character. Kahweol also has superior anti-metastatic activity (inhibiting MMP-9 and invasion) in cancer models. Commercial source: Green Coffee Extract and Oil from Herbuno deliver both cafestol and kahweol; Arabica-sourced extracts are required to obtain kahweol.

---

Evidence for Kahweol Applications

Antiproliferative and anti-angiogenic — cancer research: Kahweol inhibits angiogenesis by reducing VEGF expression and HIF-1α activity (reducing new blood vessel formation that tumours require). In colon, liver, prostate, and breast cancer cell lines, kahweol induces apoptosis and reduces migration/invasion at concentrations relevant to dietary exposure. Some evidence for synergy between kahweol and cafestol in antiproliferative activity. Claim strength: Moderate (preclinical; epidemiological support from coffee studies).

Anti-inflammatory: Like cafestol, kahweol inhibits NF-κB and COX-2. Kahweol additionally inhibits the arachidonic acid cascade at the PLA2 level, providing upstream anti-inflammatory activity. In animal arthritis and colitis models, kahweol shows anti-inflammatory efficacy comparable to or exceeding cafestol. Claim strength: Moderate.

Arabica-specific hepatoprotection: The epidemiological association between habitual coffee drinking and lower liver cancer (HCC) and cirrhosis risk has been partially attributed to cafestol + kahweol’s Nrf2-mediated hepatoprotective activity. Claim strength: Moderate (mechanistic + epidemiological; controlled human trials not completed).

---

Frequently Asked Questions — Kahweol

Why is kahweol absent from robusta coffee?
Kahweol biosynthesis requires a specific enzymatic step (insertion of the furan ring double bond) that occurs in Coffea arabica but not in Coffea canephora (robusta). The genetic basis for this species-specific difference is in the kahweol synthase gene — present in arabica but absent or non-functional in robusta. This makes kahweol a reliable chemotaxonomic marker for arabica authentication — adulteration of arabica coffee with robusta reduces or eliminates the kahweol:cafestol ratio that characterises pure arabica.

Does the furan ring in kahweol make it toxic?
Furan itself is a known hepatotoxin and IARC Group 2B possible carcinogen — formed during thermal processing of food. However, the furan ring in kahweol is embedded within the rigid diterpene scaffold in a way that does not release free furan under physiological conditions. Kahweol’s furan ring does not hydrolyse to generate free furan. The structural furan moiety in kahweol contributes to its electrophilic bioactivity (Michael acceptor capacity via α,β-unsaturation adjacent to the ring) but does not carry the hepatotoxic properties of small free furan molecules.

Is kahweol responsible for coffee’s cancer-protective associations in epidemiology?
Multiple large cohort studies (including European EPIC cohort data) show habitual coffee drinkers have lower risk of liver, colon, and endometrial cancers. The mechanistic attribution between kahweol, cafestol, chlorogenic acids, caffeine, and other coffee constituents is not resolved — all contribute to varying degrees. Kahweol’s anti-angiogenic activity is a pharmacologically plausible contributor to reduced tumour progression risk, consistent with epidemiological associations, but controlled human trials establishing kahweol-specific cancer risk reduction do not exist.

Is kahweol surviving coffee roasting?
Kahweol is partially degraded during roasting due to its additional double bond being more susceptible to oxidative and thermal degradation than cafestol. Dark roasted coffee has approximately 40–60% lower kahweol than light roasted coffee, while cafestol is more stable and declines less. Green coffee oil (Herbuno) contains the highest kahweol:cafestol ratio, with the full diterpene complement before any roasting degradation. For research or supplement applications requiring maximum kahweol content, unroasted green coffee oil is the appropriate source.

Related compounds: Cafestol, Carnosic Acid, Chlorogenic Acid, Tanshinone IIA

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery